skip to content

Cambridge Academy of Therapeutic Sciences

Read more at: MPhil in Therapeutic Sciences

MPhil in Therapeutic Sciences

The University of Cambridge and The Cambridge Academy of Therapeutic Sciences are delighted to launch the new and innovative MPhil in Therapeutic Sciences in Autumn 2018, with the first cohort of students due to begin in Autumn 2019. This one-year full-time course will select a cohort of students with the skills...

Read more

Read more at: Industry Experts in Residence (EiRs)

Industry Experts in Residence (EiRs)

Our Industry Experts in Residence are available to University of Cambridge staff for: Advice on the applicability of specific ideas to drug discovery, diagnostics & devices Advice on translational grant applications Discussions about progression of current translational research projects Work in conjunction with...

Read more


Read more at: Open Access to Drug Discovery

Open Access to Drug Discovery

The folllowing companies and not-for-profit organisations offer services and tools which support drug discovery. AstraZeneca BioAscent EMBL-EBI EU-OPENSCREEN GSK UCB AstraZeneca AstraZeneca have a number of offerings under their OpenInnovation platform including: Clinical Compound Bank Preclinical Toolbox Target Innovation...

Read more

Read more at: WT Developing Concept Fund and MRC Confidence in Concept fund

WT Developing Concept Fund and MRC Confidence in Concept fund

WT Developing Concept Fund and MRC Confidence in Concept fund CATS and OTR invite you to submit applications for internal pump-priming funding for biomedical translational research. The MRC Confidence in Concept fund is intended to accelerate the transition from discovery research to translational development projects by...

Read more


Latest news

Cambridge Heart and Lung Research Institute receives major funding boost

11 July 2019

Chris Skidmore, Minister for Universities, Science, Research and Innovation, announced on 10 July 2019 a £30 million award to the University of Cambridge to support the new Cambridge Heart and Lung Research Institute (HLRI). This is an incredibly exciting project bringing together world-renowned expertise in cardiovascular...

Widely-available antibiotics could be used in the treatment of ‘superbug’ MRSA

1 July 2019

Some MRSA infections could be tackled using widely-available antibiotics, suggests new research from an international collaboration led by scientists at the University of Cambridge and the Wellcome Sanger Institute. MRSA and other antibiotic-resistant infections are a major threat to modern medicine and we urgently need to...

Cause of hardening of the arteries – and potential treatment – identified

13 June 2019

A team of UK scientists have identified the mechanism behind hardening of the arteries, and shown in animal studies that a generic medication normally used to treat acne could be an effective treatment for the condition. Artery hardening happens to everyone as they age...but up until now we haven’t known what controls this...